One in five adults with private insurance coverage said that they or a family member had a medical service denied in the past year, even though it was recommended by their physician.
Rick Pazdur, formerly the FDA’s top oncology official, said the FDA is at a critical juncture that could determine the direction of the world’s top regulator of medicines. Pazdur spoke during a STAT panel discussion during the annual meeting of the American Society of Clinical Oncology. The post Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was appeared first on MedCity News .
Peterson Philanthropies launched Peterson Health Analytics with a $50 million commitment to help employers better understand and manage healthcare costs. The post Peterson Philanthropies Unveils Employer Health Analytics Company via $50M Commitment appeared first on MedCity News .
(MedPage Today) -- The FDA approved the Titan Prime inflatable penile prosthesis for men with erectile dysfunction, Coloplast announced on Wednesday. This prosthesis is indicated for men who are considered to be candidates for implantation of...
(MedPage Today) -- Patients highly sensitized to HLA successfully underwent kidney transplantation after desensitization with the use of dual chimeric antigen receptor (CAR) T-cell therapy. In a safety run-in cohort of an ongoing phase I trial...
(MedPage Today) -- The name of a condition that affects between 6-10% of all reproductive-age women was recently changed from PCOS (polycystic ovary syndrome) to PMOS (polyendocrine metabolic ovarian syndrome) by an international consensus process...
(MedPage Today) -- Of the five people exposed to hantavirus on a cruise ship who left a Nebraska quarantine facility for their home states, two passengers went to New York, and one each went to Arizona, California, and Oregon. At least some of...
(MedPage Today) -- LONDON -- Most patients with super-refractory, seropositive rheumatoid arthritis (RA) responded well to chimeric antigen receptor (CAR) T-cell therapy in the first part of an ongoing phase I/II trial, a researcher reported...
(MedPage Today) -- CHICAGO -- Treatment with investigational izalontamab brengitecan (iza-bren) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with unresectable locally advanced or metastatic triple...
Health experts and advocates for low-income people say federal rules implementing President Donald Trump’s new Medicaid work requirements upend months of work by state governments to prepare the computer systems that determine who’s eligible for benefits.
Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies while sidelining undifferentiated point solutions and growth-at-all-costs models. The post What Will the Next Healthcare Exit Winners Look Like? appeared first on MedCity News .